Quick Answer
Merck & Co., Inc. reported Total Assets of $136.87 billion for fiscal year 2025.
Merck & Co., Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $136.87B | +16.9% |
| 2024 | $117.11B | +9.8% |
| 2023 | $106.67B | -2.3% |
| 2022 | $109.16B | +3.3% |
| 2021 | $105.69B | +15.4% |
| 2020 | $91.59B | +8.5% |
| 2019 | $84.40B | +2.1% |
| 2018 | $82.64B | -6.0% |
| 2017 | $87.87B | -7.9% |
| 2016 | $95.38B | -6.2% |
| 2015 | $101.68B | +3.6% |
| 2014 | $98.17B | -7.1% |
| 2013 | $105.64B | -0.5% |
| 2012 | $106.13B | +1.0% |
| 2011 | $105.13B | -0.6% |
| 2010 | $105.78B | -5.8% |
| 2009 | $112.31B | +138.0% |
| 2008 | $47.20B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $129.55B | +10.2% | +10.2% |
| June 30, 2025 | $117.52B | +4.3% | +2.1% |
| March 31, 2025 | $115.12B | +8.8% | -1.7% |
| December 31, 2024 | $117.11B | +9.8% | -0.4% |
| September 30, 2024 | $117.53B | +10.1% | +4.4% |
| June 30, 2024 | $112.63B | +7.8% | +6.4% |
| March 31, 2024 | $105.85B | -1.8% | -0.8% |
| December 31, 2023 | $106.67B | -2.3% | -0.0% |
- Merck & Co., Inc. showed an increase of +16.9% in Total Assets compared to the prior fiscal year.
- Over the 2008–2025 period, Merck & Co., Inc.’s total assets has grown by 190.0% (from $47.20 billion to $136.87 billion).
- The most recent figure is from Merck & Co., Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: